 |
|
Stroke
How Large a Public Health Problem, and How Can the Neurologist Help?
Graeme J. Hankey, MBBS, MD, FRCP, FRCP(Edin), FRACP
Arch Neurol. 1999;56:748-754.
Stroke is an enormous public health problem, the magnitude of which can be reduced mainly by effective stroke prevention and less so by effective treatment of acute stroke. The greatest effect is likely to be achieved by a mass approach to prevention, which consists of modification of lifestyle behaviors (eg, less smoking and less intake of salt, alcohol, and fat) among the general population through public education and, more importantly, government legislation. The appropriate identification and treatment of high-risk individuals by neurologists is likely to have a smaller but complimentary impact on the population burden of stroke and a substantial impact on the burden of stroke among individuals. The most cost-effective interventions for patients with transient ischemic attack and ischemic stroke are organized multidisciplinary acute care and rehabilitation in a stroke unit and early secondary prevention with aspirin, blood pressure control, smoking cessation, and, in the appropriate patient, oral anticoagulant therapy and carotid endarterectomy. The cost-effectiveness of carotid endarterectomy for asymptomatic carotid stenosis is highly questionable until data from ongoing trials (eg, Asymptomatic Carotid Surgery Trial) become available. Screening for asymptomatic carotid stenosis is more likely to be harmful than helpful, except perhaps among populations with a very high prevalence (pretest probability) of severe carotid stenosis. It is essential that the impact of these strategies on the incidence, outcome, and cost of stroke is measured and monitored. Currently, this is done simply, but unreliably, by examining changes in statistics that are already being measured, such as mortality (eg, among those younger than 70 years old, for greater accuracy). A growing priority in many countries is the development and implementation of valid, reliable, practical, and inexpensive methods of routinely collecting and evaluating data on stroke incidence, outcome, and cost.
From the Stroke Unit, Department of Neurology, Royal Perth Hospital, Perth, Australia.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(6):762-764.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Level and Value of Circulating Endothelial Progenitor Cells in Patients After Acute Ischemic Stroke
Yip et al.
Stroke 2008;39:69-74.
ABSTRACT
| FULL TEXT
Update on clopidogrel and dual anti-platelet therapy: neurology
Diener
Eur Heart J Suppl 2006;8:G15-G19.
ABSTRACT
| FULL TEXT
The effect of HRT on cerebral haemodynamics and cerebral vasomotor reactivity in post-menopausal women
Bain et al.
Hum Reprod 2004;19:2411-2414.
ABSTRACT
| FULL TEXT
Comparison of Hypertension Management After Stroke and Myocardial Infarction: Results From ECLAT1--A French Nationwide Study
Amar et al.
Stroke 2004;35:1579-1583.
ABSTRACT
| FULL TEXT
Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke
Mehta et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004;286:R283-R288.
ABSTRACT
| FULL TEXT
Quantitative Assessment of the Time Course of Infarct Signal Intensity on Diffusion-Weighted Images
Eastwood et al.
Am. J. Neuroradiol. 2003;24:680-687.
ABSTRACT
| FULL TEXT
Statins in Threatened Stroke
Kaste
Stroke 2003;34:351-353.
FULL TEXT
Homonymous Visual Field Defects and Stroke in an Older Population
Gilhotra et al.
Stroke 2002;33:2417-2420.
ABSTRACT
| FULL TEXT
A national study of the quantity and cost of informal caregiving for the elderly with stroke
Hickenbottom et al.
Neurology 2002;58:1754-1759.
ABSTRACT
| FULL TEXT
Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review
Gorelick
Stroke 2002;33:862-875.
ABSTRACT
| FULL TEXT
Sleep Apnea and Cardiovascular Disease
LEUNG and DOUGLAS BRADLEY
Am. J. Respir. Crit. Care Med. 2001;164:2147-2165.
FULL TEXT
Educating the Next Generation of Physicians About Stroke: Incorporating Stroke Prevention into the Medical School Curriculum Editorial Comment: Incorporating Stroke Prevention into the Medical School Curriculum
Billings-Gagliardi et al.
Stroke 2001;32:2854-2859.
ABSTRACT
| FULL TEXT
The ABILHAND Questionnaire as a Measure of Manual Ability in Chronic Stroke Patients : Rasch-Based Validation and Relationship to Upper Limb Impairment
Penta et al.
Stroke 2001;32:1627-1634.
ABSTRACT
| FULL TEXT
Platelet glycoprotein Ib{alpha} Kozak polymorphism is associated with an increased risk of ischemic stroke
Baker et al.
Blood 2001;98:36-40.
ABSTRACT
| FULL TEXT
Stroke prevention: Narrowing the evidence-practice gap
Holloway et al.
Neurology 2000;54:1899-1906.
ABSTRACT
| FULL TEXT
Association Between High Homocyst(e)ine and Ischemic Stroke due to Large- and Small-Artery Disease but Not Other Etiologic Subtypes of Ischemic Stroke
Eikelboom et al.
Stroke 2000;31:1069-1075.
ABSTRACT
| FULL TEXT
Carotid Endarterectomy : Where Do We Draw the Line?
Gorelick
Stroke 1999;30:1745-1750.
FULL TEXT
Carotid Atherosclerotic Plaque: Noninvasive MR Characterization and Identification of Vulnerable Lesions
Yuan et al.
Radiology 2001;221:285-299.
ABSTRACT
| FULL TEXT
CT Perfusion Scanning with Deconvolution Analysis: Pilot Study in Patients with Acute Middle Cerebral Artery Stroke
Eastwood et al.
Radiology 2002;222:227-236.
ABSTRACT
| FULL TEXT
|
